Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Techne Q4 2024 Adj. EPS $0.49, Inline, Sales $306.098M Miss $306.491M Estimate

Author: Benzinga Newsdesk | August 07, 2024 06:31am
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. The company reported quarterly sales of $306.098 million which missed the analyst consensus estimate of $306.491 million by 0.13 percent. This is a 1.59 percent increase over sales of $301.320 million the same period last year.

Posted In: TECH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist